Document Detail


Electrocardiographic correlates of spontaneous termination of ventricular tachycardia in patients with coronary artery disease.
MedLine Citation:
PMID:  8353867     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: In vitro studies have reported that beat-to-beat variance in tachycardia cycle length and in conduction and repolarization properties can result in spontaneous termination of reentrant arrhythmias. The purpose of this study was to define the ECG patterns associated with spontaneous termination of ventricular tachycardia in humans late after myocardial infarction. METHODS AND RESULTS: The QRS durations, QT intervals, and cycle lengths were measured on a beat-to-beat basis during episodes of sustained and spontaneously terminating ventricular tachycardias (VT) induced at antiarrhythmic drug-free and drug-assessment electrophysiological studies. Twenty-six patients were studied. Four categories of inducible ventricular tachycardia were studied: inducible sustained ventricular tachycardia in an antiarrhythmic drug-free state, spontaneously terminating ventricular tachycardia in an antiarrhythmic drug-free state, sustained ventricular tachycardia on antiarrhythmic therapy, and spontaneously terminating ventricular tachycardia on antiarrhythmic therapy. The ECG patterns that were statistically related to spontaneous termination of ventricular tachycardia included impingement of the QTP interval on the tachycardia cycle length (P < .001) both in the presence and absence of drugs, transient shortening of QRS just before termination, and paradoxical prolongation of QTP after abrupt shortening of ventricular tachycardia cycle length. In addition, greater beat-to-beat variances in tachycardia cycle lengths, QT intervals, and QRS durations were statistically associated with spontaneously terminating ventricular tachycardia. These ECG patterns did not occur during sustained episodes of ventricular tachycardia during the antiarrhythmic drug-free state or during ineffective antiarrhythmic drug therapy. CONCLUSIONS: A dynamic interplay between QRS duration, QT interval, and cycle length of tachycardia and their variances are associated with spontaneous termination of ventricular tachycardia in humans late after infarction. This study of ECG changes associated with spontaneous termination of ventricular tachycardia provides insight into potential mechanisms of antiarrhythmic drug efficacy.
Authors:
H J Duff; L B Mitchell; A M Gillis; R S Sheldon; L Chudleigh; P Cassidy; N Chiamvimonvat; D G Wyse
Related Documents :
2022017 - Functional role of the epicardium in postinfarction ventricular tachycardia. observatio...
3385917 - Observations on rapid ventricular pacing during reentrant ventricular tachycardia in ca...
1183467 - Double ectopic accelerated ventricular and nonaccelerated ventricular or supraventricul...
11096537 - Ventricular arrhythmias.
20562067 - Percutaneous coronary interventions in europe in 2006.
6301887 - Modulation of myocardial cyclic amp and vulnerability to fibrillation in the rat heart.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Circulation     Volume:  88     ISSN:  0009-7322     ISO Abbreviation:  Circulation     Publication Date:  1993 Sep 
Date Detail:
Created Date:  1993-09-23     Completed Date:  1993-09-23     Revised Date:  2010-03-24    
Medline Journal Info:
Nlm Unique ID:  0147763     Medline TA:  Circulation     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1054-62     Citation Subset:  AIM; IM    
Affiliation:
Department of Medicine, University of Calgary, Foothills Hospital, Alberta, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Arrhythmia Agents / therapeutic use*
Cardiac Pacing, Artificial
Coronary Disease / complications*
Electrocardiography*
Female
Heart Conduction System / physiopathology*
Humans
Male
Middle Aged
Myocardial Infarction / complications*
Tachycardia, Ventricular / drug therapy,  etiology,  physiopathology*
Chemical
Reg. No./Substance:
0/Anti-Arrhythmia Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Chronic atrial fibrillation and stroke in paced patients with sick sinus syndrome. Relevance of clin...
Next Document:  Frequency-dependent electrophysiologic effects of amiodarone in humans.